Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. junior Avg
|
New words:
addressed, anticorruption, attention, Augmenix, bad, bridge, convergence, denial, ethical, Haan, Helsinki, hydrogel, led, media, Ministry, notwithstanding, proceed, retrofit, Shonin, shutting, slight, stemming, Welfare
Removed:
antitrust, ASU, department, proportion, temporary
Filing tables
Filing exhibits
- 10-Q Quarterly report
- 15.1 Letter Regarding Unaudited Interim Financial Information
- 31.1 Chief Executive Officer Certification Pursuant to Rule 13A-14(A)
- 31.2 Chief Financial Officer Certification Pursuant to Rule 13A-14(A)
- 32.1 Chief Executive Officer Certification Pursuant to 18 U.s.c. Section 1350
- 32.2 Chief Finacial Officer Certification Pursuant to 18 U.s.c. Section 1350
Related press release
VAR similar filings
Filing view
External links
Exhibit 32.2
CERTIFICATION
PURSUANT TO 18 U.S.C. SECTION 1350
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the accompanying Quarterly Report of Varian Medical Systems, Inc. (the “Company”), on Form 10-Q for the quarter ended July 1, 2011 (the “Report”), I, Elisha W. Finney, Senior Vice President, Finance and Chief Financial Officer of the Company, hereby certify pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002 that:
(1) | the Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
(2) | the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
Dated: August 10, 2011 | /s/ ELISHA W. FINNEY | |||
Elisha W. Finney | ||||
Senior Vice President, Finance and | ||||
Chief Financial Officer |